ResearchMoz

Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

GBI Research
Published Date » 2013-05-03
No. Of Pages » N/A
   
 GBI Research’s report Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market looks at the regulatory landscape and reimbursement scenario in the US for four medical device markets: cardiovascular devices, neurostimulation devices, diagnostic imaging devices and endoscopy devices.  
   
 The report provides comprehensive information on establishment registration, medical device listing, Premarket Notification (510k) or Premarket Approval (PMA), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, labeling requirements, and Medical Device Reporting (MDR). The report also reviews the reimbursement scenario in these medical device markets. It is built using data and information sourced from proprietary...
Table of Content

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Executive Summary 5
2.1 Obtaining Marketing Clearance for Medical Devices Involves Three Essential Steps 5
2.2 The US Transcatheter Heart Valves Market is Forecast to Witness High Growth Between 2012 and 2019 due to Favorable Reimbursement 5
2.3 Strong Reimbursement Framework is Expected to Drive the US Endoscopy Device Market 6

3 Introduction 8

4 Overview of the Healthcare Reform Bill 9

5 Regulatory Landscape in the US 17
5.1 Overview of Medical Device Regulation 17
5.1.1 Establishment Registration 18
5.1.2 Medical Device Listing 19
5.1.3 New Medical Device Approval Process 19
5.1.3.1 Premarket Notification or 510(k) 21
5.1.3.2 Premarket Approval 23
5.1.3.3 Other Device Regulations 24
5.1.4 Quality System Regulation/Good Manufacturing Practices 24
5.1.5 Labeling 25
5.1.6 Medical Device Reporting 26

6 Changing Reimbursement Scenario in the Medical Device Market 28
6.1 Cardiovascular Devices 28
6.1.1 Reimbursement Coverage for Transcatheter Aortic Valve Replacement 28
6.1.1.1 Transcatheter Heart Valves Market in the US is Expected to Exceed $3 billion by 2019 at a CAGR of 45% 29
6.1.2 Reimbursement Coverage for Artificial Hearts and Related Devices 30
6.1.2.1 Left Ventricular Assist Devices Market in the US is Expected to More than Double during the Forecast Period 31
6.1.3 Reimbursement Coverage for Percutaneous Transluminal Angioplasty 32
6.2 Neurostimulation Devices 34
6.2.1 Reimbursement Coverage for Transcutaneous Electrical Nerve Stimulation 34
6.3 Diagnostic Imaging Devices 36
6.3.1 Reimbursement Coverage for Magnetic Resonance Imaging 36
6.3.2 Reimbursement Coverage for Positron Emission Tomography Scans 37
6.3.3 Reimbursement Cuts for Diagnostic Imaging Services 38
6.4 Endoscopy Devices 38
6.4.1 Reimbursement Coverage for Capsule Endoscope Systems 38
6.4.1.1 Capsule Endoscopy Systems Market in the US is Expected to Double during the Forecast Period 40

7 Appendix 43
7.1 Definitions 43
7.2 Acronyms 43
7.3 Sources 44
7.4 Research Methodology 46
7.4.1 Secondary Research 46
7.4.2 Primary Research 46
7.4.3 Models 47
7.4.4 Forecasts 47
7.4.5 Expert Panels 47
7.5 Contact Us 47
7.6 Disclaimer 48

List of Tables

Table 1: Food and Drug Administration, US, Classification Regulations 20
Table 2: Food and Drug Administration, US, Device Labeling 25
Table 3: Food and Drug Administration. US, Reporting Requirements for Manufacturers 26
Table 4: Food and Drug Administration, US, Reporting Requirements for User Facilities 26
Table 5: Transcatheter Heart Valves Market, US, Revenue Forecast ($m), 2012–2019 29
Table 6: Left Ventricular Assist Devices Market, US, Revenue Forecast ($m), 2012–2019 31
Table 7: Capsule Endoscope Systems Market, US, Revenue Forecast ($m), 2012–2019 41

List of Figures


Figure 1: Transcatheter Heart Valves Market, US, Revenue Forecast ($m), 2012–2019 6
Figure 2: Key Healthcare Reform Provisions, US, 2010 10
Figure 3: Key Healthcare Reform Provisions, US, 2010 11
Figure 4: Key Healthcare Reform Provisions, US, 2010 12
Figure 5: Key Healthcare Reform Provisions, US, 2010 13
Figure 6: Key Healthcare Reform Provisions, US, 2010 14
Figure 7: Key Healthcare Reform Provisions, US, 2010 15
Figure 8: Key Healthcare Reform Provisions, US, 2010 16
Figure 9: Key Healthcare Reform Provisions, US, 2010 16
Figure 10: Food and Drug Administration, US, Organizational Structure 17
Figure 11: Food and Drug Administration, US, Basic Regulatory Requirements 18
Figure 12: Food and Drug Administration, US, Regulations for Approval of New Medical Device 22
Figure 13: Transcatheter Heart Valves Market, US, Revenue Forecast ($m), 2012–2019 29
Figure 14: Left Ventricular Assist Devices Market, US, Revenue Forecast ($m), 2012–2019 31
Figure 15: Capsule Endoscope Systems Market, US, Revenue Forecast ($m), 2012–2019 41

Upcoming Reports:

Poland: native sulphur market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the native sulphur market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the native sulphur market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of...
Drug Delivery Across The Blood-Brain Barrier Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Blood brain barrier refers to a set of special tight junctions formed around the microvasculature of the brain to gain the optimal neural functioning. The primary function of blood brain barrier is to protect the brain from harmful toxins that are potentially present in the blood stream and allows the passage of lipid soluble, oxygen and carbon dioxide to perform the normal cellular function of brain. In a way to protect brain from noxious agents the blood brain barrier also significantly hinders the delivery of therapeutics to brain. This makes treatment of brain disorders and infections...
Bituminous Paints Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Bituminous paints are paints containing high quantity of bitumen, a highly viscous, sticky and black colored liquid compound. Bitumen contains high quantity of hydrocarbons and is a petroleum product with tar like appearance. Bitumen is produced by fractional distillation of crude oil or crude oil based products. Crude oil is processed at a temperature generally between 300 to degree Celsius to 350 degree Celsius. Heated crude oil is then processed in a distillation column to separate light fractions of the oil by vaporization. The fractions with higher boiling point remaining in the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Technology License Deal Signed between Sumitomo Chemical and Universal Display
Jan 22, 2015  
A new OLED technology license agreement has been signed between Sumitomo Chemical Company Ltd., and Universal Display Corporation. This agreement states that non-exclusive license rights have been granted to Sumitomo Chemical by Universal Display. These rights come within the ambit of several patents that are controlled and owned by Universal Display for manufacturing and selling processed...
Utah: Ranks No. 2 in Toxic Chemical Emissions
Jan 22, 2015  
As per reports, it has been observed and concluded that Utah has the maximum number of open-pit copper mines in the entire world, and this involves huge volumes of lead compounds. The annual inventory of Environmental Protection Agency denotes that Utah holds the second position amidst 56 states and territories all over the country for toxic and harmful releases per square mile. ...
The Production of Bio-based Materials and Chemicals to Increase Significantly by 2018
Jan 22, 2015  
It is expected that the global production capacity of bio-based materials and chemicals will increase significantly by 2018. The growth will primarily be driven by growth taking place in Brazil, and the U.S. As a result, with the help of the emerging technologies the production will be greater than 7.4 million metric tons. Also, the market for bio-based materials and chemicals will be fueled...
Maxx Mobilink Announces its Plan to Manufacture in India
Jan 22, 2015  
Maxx Mobilink, Indian smartphone manufacturer intends to start making mobile handsets at its Haridwar plant. This plan will only materialize after the manufacturer has assembled devices starting April at its factory where it presently makes charger, batteries, and other such accessories. The mobile manufacturer’s plan is in accordance with Prime Minister’s appeal to the nation to...
Ontario to Benefit from Western Canadas Loss
Jan 22, 2015  
As oil prices are hitting a new low in Canada, the country cannot help but turn to Ontario to make some recovery. Presently, Ontario is Canada’s only hope to sustain its growth in manufacturing. It was in December last year that TD Economics predicted that Ontario will help Canada achieve growth at a rapid pace with a 2.6% hike in GDP in 2015. The current economic winds are suggestive of...